Although analysis of CRC immune-contexture is increasingly gaining clinical relevance [4-6], prognostic significance of OX40 expression in CRC infiltrating cells has only been explored in one study evaluating a cohort of 72 patients [25]. The gene discussed is TNFRSF4; the disease is colorectal carcinoma.